RNU7-195P

Across TCGA pan-cancer cohorts, RNU7-195P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated RNU7-195P data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher RNU7-195P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU7-195P expression acts as an unfavorable survival marker, although some lineages such as BLCA and SKCM show a favorable association.

CHOL, READ, and KICH are the cancer types where RNU7-195P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	II,III,IV	0.019	0.675	<.001	72	view →
READ	OS	Tertile	IV	0.111	0.893	<.001	27	view →
KICH	DFS	Tertile	III,IV	0.061	0.788	.009	27	view →
BLCA	DFS	Tertile	III,IV	1.000	0.451	.018	24	view →
UCEC	DFS	Tertile	III,IV	0.583	0.807	.024	24	view →
GBM	DFS	Tertile	All	0.151	0.272	.008	18	view →
LUAD	DFS	Tertile	IV	0.223	0.710	.043	18	view →
THCA	OS	Tertile	All	0.654	0.959	.026	18	view →
SKCM	DFS	Tertile	All	0.871	0.599	.023	12	view →
ESCA	OS	Quartile	II,III,IV	0.512	0.700	.012	9	view →
PAAD	OS	Tertile	II,III,IV	0.335	0.571	.018	9	view →
PRAD	OS	Tertile	All	0.968	0.993	.033	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

RNU7-195P–CHOL (OS)

Open the CHOL breakdown →